SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-120279
Filing Date
2020-11-02
Accepted
2020-11-02 09:01:00
Documents
1
Period of Report
2020-10-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 tm2034740d1_form4.html 4  
1 FORM 4 tm2034740d1_form4.xml 4 3067
  Complete submission text file 0001104659-20-120279.txt   4582
Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 (973) 242-0005
Neurotrope, Inc. (Issuer) CIK: 0001513856 (see all company filings)

IRS No.: 463522381 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O ATRINSIC, INC. 1 GRAND CENTRAL PLACE SUITE 2319 NEW YORK NY 10165
Business Address
SCHECHTER JONATHAN (Reporting) CIK: 0001619259 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38045 | Film No.: 201279107